trial · primary record
WJB001
Advanced Solid Tumors
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 63 |
| Primary completion | 2028-07-31 |
| Primary endpoint | 1.Dose limited toxicity (DLT) |
| Registry ID | NCT05773820 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:10.015Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05773820
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.